Article | October 2, 2018

USP <1207> Updates Leak Testing Recommendations for Pharmaceutical Companies

By Hemi Sagi

Pfeiffer Vacuum Logo-3c (002)

Package integrity is defined as a package’s ability to prevent product loss, maintain product sterility, and in some cases, prevent oxygen ingress or maintain sub-atmosphere headspace pressures. As a result, container closure integrity testing is an important step in the preparation and transportation of many different products. Unlike other mass produced devices, blood filters, catheters, diagnostic probes, syringes, ventilator tubes and other items must meet strict requirements set by the Food and Drug Administration (FDA).

Last fall the United States Pharmacopeia (USP) released the proposed revisions to general chapter Sterile Product Packaging – Integrity Evaluation <1207> for public comment in the Pharmacopeial Forum. USP <1207> is designed to offer guidance on container closure integrity leak testing methods and qualification. 

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: